Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis

被引:35
作者
Jiménez-Jiménez, FJ
Hernánz, A
Medina-Acebrón, S
de Bustos, F
Zurdo, JM
Alonso, H
Puertas, I
Barcenilla, B
Sayed, Y
Cabrera-Valdivia, F
机构
[1] Univ Alcala de Henares, Hosp Univ Principe Asturias, Dept Neurol, Madrid, Spain
[2] Dept Biochem, Ciudad Sanitaria La Paz, Spain
[3] Hosp Nuestra Senora Prado, Dept Biochem, Toledo, Spain
来源
ACTA NEUROLOGICA SCANDINAVICA | 2005年 / 111卷 / 02期
关键词
amyotrophic lateral sclerosis; motoneuron disease; tau protein; cerebrospinal fluid;
D O I
10.1111/j.1600-0404.2005.00370.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective - To elucidate whether cerebrospinal fluid (CSF) concentrations of the microtubule-associated tau protein are related to the risk for sporadic amyotrophic lateral sclerosis (SALS). Patients/Methods - We measured tau concentrations in the CSF of 18 patients with SALS and 75 age- and sex-matched controls, using a specific ELISA method. Results - The mean CSF concentrations of tau protein did not differ significantly between SALS patient and control groups, were not influenced by the clinical form (spinal vs bulbar) of ALS, and were not correlated with age, age at onset, and duration of the disease. Conclusions - CSF tau concentrations are not a biochemical marker of ALS.
引用
收藏
页码:114 / 117
页数:4
相关论文
共 33 条
[1]   MODIFICATIONS OF MICROTUBULE PROTEINS IN ALS NERVE PRECEDE DETECTABLE HISTOLOGIC AND ULTRASTRUCTURAL-CHANGES [J].
BINET, S ;
MEININGER, V .
NEUROLOGY, 1988, 38 (10) :1596-1600
[2]   DEFECTIVE AXONAL-TRANSPORT IN A TRANSGENIC MOUSE MODEL OF AMYOTROPHIC-LATERAL-SCLEROSIS [J].
COLLARD, JF ;
COTE, F ;
JULIEN, JP .
NATURE, 1995, 375 (6526) :61-64
[3]  
CORIA F, 1996, NEUROLOGIA SPAIN S3, V11, P118
[4]   PATHOLOGICAL TAU-PROTEINS OF ALZHEIMERS-DISEASE AS A BIOCHEMICAL MARKER OF NEUROFIBRILLARY DEGENERATION [J].
DELACOURTE, A .
BIOMEDICINE & PHARMACOTHERAPY, 1994, 48 (07) :287-295
[5]   Altered levels and distribution of microtubule-associated proteins before disease onset in a mouse model of amyotrophic lateral sclerosis [J].
Farah, CA ;
Nguyen, MD ;
Julien, JP ;
Leclerc, N .
JOURNAL OF NEUROCHEMISTRY, 2003, 84 (01) :77-86
[6]  
Ferrer I, 1996, Neurologia, V11 Suppl 5, P7
[7]   Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform [J].
Ishihara, T ;
Hong, M ;
Zhang, B ;
Nakagawa, Y ;
Lee, MK ;
Trojanowski, JQ ;
Lee, VMY .
NEURON, 1999, 24 (03) :751-762
[8]   Neurofilament functions in health and disease [J].
Julien, JP .
CURRENT OPINION IN NEUROBIOLOGY, 1999, 9 (05) :554-560
[9]   Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects? [J].
Julien, JP ;
Beaulieu, JM .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 180 (1-2) :7-14
[10]   Increased cerebrospinal fluid tau protein in multiple sclerosis [J].
Kapaki, E ;
Paraskevas, GP ;
Michalopoulou, M ;
Kilidireas, K .
EUROPEAN NEUROLOGY, 2000, 43 (04) :228-232